Searchable abstracts of presentations at key conferences in endocrinology

ea0054p2 | (1) | NuclearReceptors2018

Next generation glucocorticoid receptor modulators

Edman Karl , Belfield Graham , Dearman Matthew , Edenro Goran , Geschwindner Stefan , Hegelund-Myrback Tove , Hemmerling Martin , Hendrickx Ramon , Keen Christina , Karrman-Mardh Carina , Lepisto Matti , Mitra Suman , Monkley Susan , Prothon Susanne , Ripa Lena , Steele John , Vaarala Outi , Wissler Lisa , Oberg Lisa

Synthetic glucocorticoids bind to the glucocorticoid receptor (GR) and have been used for nearly 70 years to treat inflammatory diseases. However, their use is limited by adverse effects such as diabetes, muscle wasting and osteoporosis. High throughput screening identified a novel non-steroidal scaffold with great potential for chemical optimization. Through rational design we developed the indazole ether series which combines high potency with structural motifs that provide ...

ea0070aep567 | Pituitary and Neuroendocrinology | ECE2020

Multigene liquid biopsy (NETest) is diagnostic of pancreatic and small bowel neuroendocrine tumours and correlates with imaging

Malczewska Anna , Witkowska Magdalena , Makulik Karolina , Bocian Agnes , Walter Agata , Wojcik-Giertuga Monika , Pilch-Kowalczyk Joanna , Zajecki Wojciech , Bodei Lisa , Oberg Kjell , Kos-Kudla Beata

Introduction: There is a substantial unmet clinical need for an accurate and effective blood biomarker for gastroenteropancreatic neuroendocrine tumours (GEP-NETs). Current monoanalyte biomarkers are ineffective. The NETest, a novel multianalyte signature, provides molecular information relevant to disease biology. We therefore evaluated, under real-world conditions, the clinical utility of the NETest as a liquid biopsy in GEP-NETs.Aim(s): Independently ...